Adial Pharmaceuticals has received feedback from FDA on the AD04 phase 3 adaptive clinical trial design and broader clinical development strategy.

Peer mentoring enhances psychiatric care by supporting new providers, reducing burnout, and fostering collaboration among NPs and PAs in mental health.

Timing hormone replacement therapy post-menopause significantly influences Alzheimer disease risk, with early treatment offering protective benefits against cognitive decline.

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.

"What they taught in school was not what we needed, and what we needed (they said) could not be conveyed."

Explore the impact of moral injuries on health care workers and the need for systemic change to support their well-being and mental health.

Discover effective strategies to build resilience and thrive through life's challenges, from personal growth to support systems and professional help.

New research highlights the effectiveness of early psychosis intervention programs, emphasizing low caseloads and clozapine access to reduce relapse rates.

Explore the evolving landscape of moral injury treatment in health care, emphasizing trust, advocacy, and innovative therapeutic approaches.

America is in the world, the world is in America.

Shelly Jo Kraft, MS, PhD, lays the foundation for a new approach that emphasizes the role of comorbidities in stuttering.

Shahriar SheikhBahaei, PhD, discusses how animal models may lead to better treatments.

Collaborating with speech pathologists and others improve care for patients who stutter.

Shahriar SheikhBahaei, PhD, shares insights into the neurobiology of stuttering at STARS conference.

Gerald A. Maguire, MD, details the unmet needs in stuttering at the inaugural conference.

Discover how nutrition plays a crucial role in managing bipolar disorder, emphasizing individualized dietary strategies for mood stabilization.

Discover how blarcamesine, a novel therapy for Alzheimer disease, shows promise in preventing cognitive decline and enhancing patient quality of life.

Simplistic explanations and convenient scapegoats belie the complexity of mass shootings.

Cognitive behavioral therapy for insomnia effectively treats chronic insomnia, promoting long-term sleep improvement through targeted behavioral strategies.

Moral injuries in health care professionals became an increasing focus during the COVID-19 pandemic, with all the obstacles, uncertainty, and risks of patient care.

"This can still happen anywhere. Not everything is lost."

More than 20 years later, what have we learned about PTSD, resiliency, and trauma?

Susan Noonan, MD, discusses emerging research on the potential role of lithium deficiency in Alzheimer disease.